For the first time, this study demonstrated that pancreatic stellate cell (PSC) activation is a central mechanism of the pro-tumoral effects of CTHRC1 and elucidated the plasticity of the tumor microenvironment (TME) following CTHRC1-targeted pancreatic cancer treatment. This evidence concerns the gene CTHRC1 and familial pancreatic carcinoma.